icon-folder.gif   Conference Reports for NATAP  
  HIV Glasgow
23-26 October 2016
Glasgow, UK
Back grey_arrow_rt.gif
Discontinuation of Dolutegravir (DTG)-based Regimens in Clinical Practice
  Reported by Jules Levin
HIV Glasgow 2016 Oct 23-26
Vivancos-Gallego, MJ1; Moreno, A1; Perez Elias, MJ1; Gomez Ayerbe, C1; Casado, JL1; Quereda, C1; Sanchez-Conde, M1; Serrano Villar, S1; Dronda, F1; Navas, E1; Rodriguez, MA2; Moreno, S1. Hospital Ramón y Cajal, IRYCIS Infectious Diseases Madrid Spain1; Hospital Ramón y Cajal, IRYCIS Pharmacy Department Madrid Spain2


- In our real life cohort we did find a high proportion of DTG discontinuation that was attributable not only to toxicity.
- CNS adverse events are the most frequent cause of discontinuation.
- Ongoing pharmacovigilance is important to identify events that might be associated with the drug.